Parasitological cure rate of praziquantel treatment.
收藏NIAID Data Ecosystem2026-03-10 收录
数据链接：
官方服务：
资源简介：
Parasitological cure rate of praziquantel treatment.
应用场景：
创建时间：
2018-10-29
相关数据集
Overview of included RRMS phase-3 trials (n = 13).
RRF = Rate of relapse free patients after 2 years, SE = Standard error, ARR = Annualized relapse rate over 2 years, SD = Standard deviation, 2001/2005 indicates the use of the original 2001 McDonald c
Figshare2015-12-02 更新50
Supplementary Material for: A Phase 2 Study of Camrelizumab for Advanced Hepatocellular Carcinoma: Two-Year Outcomes and Continued Treatment beyond First RECIST-Defined Progression
Introduction: In a multicenter, open-label, parallel-group, randomized, phase 2 study for pretreated advanced hepatocellular carcinoma (HCC), camrelizumab showed potent antitumor activity and acceptab
NIAID Data Ecosystem50
Quality health indicators achieved over the first 12 months of observation, stratified by treatment allocation (N = 818).
Quality health indicators achieved over the first 12 months of observation, stratified by treatment allocation (N = 818).
Figshare2022-11-02 更新30
COR peak week 1 improvement and COR peak week 5 improvement.
Response and remission rates after 5 weeks of treatment in 40 depressed patients (sample 2) treated with either reboxetine (n = 20) or mirtazapine (n = 20) [33]. Patients are subdivided into COR peak
NIAID Data Ecosystem50
An Observational Study of Adjuvant Treatment With Capecitabine (Xeloda) in Combination With Oxaliplatin in Participants With Stage III Colon Cancer
This observational study evaluates the efficacy and safety of capecitabine in combination with oxaliplatin in the adjuvant setting in participants with Stage III colon cancer. Data were collected from
NIAID Data Ecosystem40
